Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.59 |
| ▸ | ACHE | P22303 | 7/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18274515 | 0.86 | ALDH1A1 (0.61) | ALDH1A1ACHETSHRRAB9ASMN1; SMN2 | |
| SCHEMBL11259596 | 0.78 | ALDH1A1 (0.65) | ALDH1A1ACHETSHRRAB9ASMN1; SMN2 | |
| SCHEMBL11263177 | 0.76 | ALDH1A1 (0.62) | ALDH1A1ACHETSHRRAB9ASMN1; SMN2 | |
| SCHEMBL15797643 | 0.73 | AKT1S1 (0.36) | TSHRHPGD | |
| SCHEMBL15797642 | 0.72 | GAA (0.41) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL18274460 | 0.71 | ALDH1A1 (0.59) | ALDH1A1ACHETSHRRAB9ASMN1; SMN2 | |
| SCHEMBL519228 | 0.71 | ALDH1A1 (0.69) | ALDH1A1ACHETSHRRAB9ASMN1; SMN2 | |
| SCHEMBL18274474 | 0.70 | ACHE (0.54) | ALDH1A1ACHETSHRRAB9ASMN1; SMN2 | |
| SCHEMBL12701354 | 0.69 | ALDH1A1 (0.53) | ALDH1A1ACHETSHRRAB9ASMN1; SMN2 | |
| SCHEMBL18274462 | 0.69 | ALDH1A1 (0.53) | ALDH1A1ACHETSHRRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2931717-B1 | INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2016-12-07 | — | — | EP | disclosed |